Literature DB >> 24570946

Histamine regulation of pancreatitis and pancreatic cancer: a review of recent findings.

Taylor Francis1, Allyson Graf2, Kyle Hodges3, Lindsey Kennedy3, Laura Hargrove3, Mattie Price3, Kate Kearney3, Heather Francis4.   

Abstract

The pancreas is a dynamic organ that performs a multitude of functions within the body. Diseases that target the pancreas, like pancreatitis and pancreatic cancer, are devastating and often fatal to the suffering patient. Histamine and histamine receptors (H1-H4HRs) have been found to play a critical role in biliary diseases. Accordingly, the biliary tract and the pancreas share similarities with regards to morphological, phenotypical and functional features and disease progression, studies related the role of H1-H4HRs in pancreatic diseases are important. In this review, we have highlighted the role that histamine, histidine decarboxylase (HDC), histamine receptors and mast cells (the main source of histamine in the body) play during both pancreatitis and pancreatic cancer. The objective of the review is to demonstrate that histamine and histamine signaling may be a potential therapeutic avenue towards treatment strategies for pancreatic diseases.

Entities:  

Keywords:  Histamine; pancreas; pancreatic cancer; pancreatitis

Year:  2013        PMID: 24570946      PMCID: PMC3924685          DOI: 10.3978/j.issn.2304-3881.2013.08.06

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


  72 in total

1.  Oxaliplatin combined with 5-FU in second line treatment of advanced pancreatic adenocarcinoma. Results of a phase II trial.

Authors:  Emmanuel Mitry; Michel Ducreux; Mahmoud Ould-Kaci; Valérie Boige; Jean-François Seitz; Roland Bugat; Jean-Luc Breau; Olivier Bouché; Pierre-Luc Etienne; Jean-Marie Tigaud; François Morvan; Esteban Cvitkovic; Philippe Rougier
Journal:  Gastroenterol Clin Biol       Date:  2006-03

2.  Histamine stimulates the proliferation of small and large cholangiocytes by activation of both IP3/Ca2+ and cAMP-dependent signaling mechanisms.

Authors:  Heather L Francis; Sharon Demorrow; Antonio Franchitto; Julie K Venter; Romina A Mancinelli; Mellanie A White; Fanyin Meng; Yoshiyuki Ueno; Guido Carpino; Anastasia Renzi; Kimberly K Baker; Hannah E Shine; Taylor C Francis; Eugenio Gaudio; Gianfranco D Alpini; Paolo Onori
Journal:  Lab Invest       Date:  2011-11-07       Impact factor: 5.662

3.  Does stress play a role in the development of severe pancreatitis in rats?

Authors:  H Yamaguchi; T Kimura; H Nawata
Journal:  Gastroenterology       Date:  1990-06       Impact factor: 22.682

4.  Pancreatic and pulmonary mast cells activation during experimental acute pancreatitis.

Authors:  Inmaculada Lopez-Font; Sabrina Gea-Sorlí; Enrique de-Madaria; Luis M Gutiérrez; Miguel Pérez-Mateo; Daniel Closa
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

Review 5.  Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances.

Authors:  Tetsuhide Ito; Hisato Igarashi; Robert T Jensen
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-12       Impact factor: 3.043

6.  Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study.

Authors:  V Heinemann; R Labianca; A Hinke; C Louvet
Journal:  Ann Oncol       Date:  2007-07-28       Impact factor: 32.976

7.  New developments in the treatment of pancreatic cancer. Highlights from the "44th ASCO Annual Meeting". Chicago, IL, USA. May 30 - June 3, 2008.

Authors:  Muhammad Wasif Saif
Journal:  JOP       Date:  2008-07-10

Review 8.  Role of histamine H4 receptors in the gastrointestinal tract.

Authors:  Gabriella Coruzzi; Maristella Adami; Cristina Pozzoli
Journal:  Front Biosci (Schol Ed)       Date:  2012-01-01

9.  Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis.

Authors:  Ihsan Ekin Demir; Stephan Schorn; Elisabeth Schremmer-Danninger; Kun Wang; Timo Kehl; Nathalia A Giese; Hana Algül; Helmut Friess; Güralp O Ceyhan
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

10.  Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses.

Authors:  A Sultana; C Tudur Smith; D Cunningham; N Starling; J P Neoptolemos; P Ghaneh
Journal:  Br J Cancer       Date:  2008-06-24       Impact factor: 7.640

View more
  4 in total

1.  microRNA-218 promotes gemcitabine sensitivity in human pancreatic cancer cells by regulating HMGB1 expression.

Authors:  Zhe Liu; Ruixia Du; Jin Long; Kejian Guo; Chunlin Ge; Shulong Bi; Yuanhong Xu
Journal:  Chin J Cancer Res       Date:  2015-06       Impact factor: 5.087

Review 2.  Mast cells and angiogenesis in pancreatic ductal adenocarcinoma.

Authors:  Vito Longo; Roberto Tamma; Oronzo Brunetti; Salvatore Pisconti; Antonella Argentiero; Nicola Silvestris; Domenico Ribatti
Journal:  Clin Exp Med       Date:  2018-02-28       Impact factor: 3.984

3.  MicroRNA-221 induces autophagy through suppressing HDAC6 expression and promoting apoptosis in pancreatic cancer.

Authors:  Yifan Yang; Yang Sun; Huaitao Wang; Hansi Li; Mingjie Zhang; Lei Zhou; Xiangli Meng; Yunhao Wu; Peng Liu; Xin Liu; Jun Zhang; Xiaodong Tan
Journal:  Oncol Lett       Date:  2018-09-27       Impact factor: 2.967

4.  microRNA-218 suppresses the proliferation, invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1.

Authors:  Zhe Liu; Yuanhong Xu; Jin Long; Kejian Guo; Chunlin Ge; Ruixia Du
Journal:  Chin J Cancer Res       Date:  2015-06       Impact factor: 5.087

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.